Prothena Historical Balance Sheet

PRTA Stock

USD 13.78 1.22 8.13%

Trend analysis of Prothena plc balance sheet accounts such as Total Stockholder Equity of 325.8 M, Other Liab of 103.7 M, Accounts Payable of 26.7 M or Other Assets of 37.3 M provides information on Prothena Plc's total assets, liabilities, and equity, which is the actual value of Prothena plc to its prevalent stockholders. By breaking down trends over time using Prothena Plc balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Prothena plc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Prothena plc is a good buy for the upcoming year.

Prothena Plc Inventory

(4.9 Million)

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.

About Prothena Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Prothena plc at a specified time, usually calculated after every quarter, six months, or one year. Prothena Plc Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Prothena Plc and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Prothena currently owns. An asset can also be divided into two categories, current and non-current.

Prothena Plc Balance Sheet Chart

At present, Prothena Plc's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 59.7 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 35.1 M.

Common Stock Shares Outstanding Total Assets Total Current Liabilities Other Liab

Add Fundamental

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of Prothena Plc assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Prothena plc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Prothena Plc balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Prothena plc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Prothena Plc's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Prothena plc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.At present, Prothena Plc's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 59.7 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 35.1 M.

	2021	2022	2023	2024 (projected)
Accounts Payable	3.7M	9.3M	25.4M	26.7M
Other Liabilities	103.5M	85.8M	98.7M	103.7M

Accounts Payable Other Liab

Prothena Plc balance sheet Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Accounts Payable	Other Assets	Total Liab	Property Plant Equipment	Property Plant And Equipment Net	Non Current Assets Total	Non Currrent Assets Other	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Property Plant And Equipment Gross	Total Current Assets	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Inventory	Common Stock
Common Stock Shares Outstanding		0.94	0.05	0.77	0.86	0.76	0.5	0.76	0.9	0.23	0.42	0.7	0.67	0.78	0.74	0.98	-0.14	0.93	-0.87	-0.9	0.93	0.93	0.28	1.0	-0.25	0.99
Total Assets	0.94		0.07	0.79	0.98	0.6	0.53	0.68	0.78	0.31	0.41	0.69	0.8	0.63	0.81	0.95	0.04	1.0	-0.92	-0.79	0.98	0.98	0.26	0.95	-0.27	0.96
Other Current Liab	0.05	0.07		0.43	0.17	-0.23	0.47	0.21	-0.25	-0.3	-0.26	-0.14	0.12	-0.41	0.36	0.06	-0.22	0.1	-0.19	-0.07	0.11	0.11	0.33	0.06	-0.3	0.09
Total Current Liabilities	0.77	0.79	0.43		0.79	0.49	0.88	0.85	0.57	0.28	0.35	0.62	0.72	0.39	0.91	0.79	-0.17	0.8	-0.87	-0.8	0.82	0.82	0.62	0.79	-0.58	0.83
Total Stockholder Equity	0.86	0.98	0.17	0.79		0.45	0.57	0.6	0.62	0.27	0.31	0.59	0.81	0.45	0.84	0.87	0.1	0.98	-0.91	-0.68	0.96	0.96	0.3	0.87	-0.33	0.89
Other Liab	0.76	0.6	-0.23	0.49	0.45		0.28	0.74	0.87	-0.05	0.21	0.44	0.34	0.89	0.49	0.78	-0.36	0.61	-0.65	-0.9	0.62	0.62	0.3	0.76	-0.22	0.77
Accounts Payable	0.5	0.53	0.47	0.88	0.57	0.28		0.74	0.28	0.28	0.29	0.51	0.51	0.13	0.8	0.53	-0.02	0.54	-0.64	-0.61	0.55	0.55	0.85	0.54	-0.83	0.57
Other Assets	0.76	0.68	0.21	0.85	0.6	0.74	0.74		0.7	0.13	0.28	0.58	0.61	0.6	0.77	0.81	-0.3	0.68	-0.76	-0.92	0.7	0.7	0.59	0.78	-0.49	0.81
Total Liab	0.9	0.78	-0.25	0.57	0.62	0.87	0.28	0.7		0.34	0.57	0.76	0.55	0.97	0.47	0.88	-0.15	0.75	-0.67	-0.87	0.74	0.74	0.08	0.88	-0.02	0.87
Property Plant Equipment	0.23	0.31	-0.3	0.28	0.27	-0.05	0.28	0.13	0.34		0.93	0.81	0.39	0.3	0.07	0.19	0.48	0.24	-0.11	-0.12	0.21	0.21	-0.08	0.23	0.04	0.21
Property Plant And Equipment Net	0.42	0.41	-0.26	0.35	0.31	0.21	0.29	0.28	0.57	0.93		0.9	0.37	0.55	0.09	0.36	0.39	0.33	-0.19	-0.33	0.3	0.3	-0.07	0.41	0.07	0.38
Non Current Assets Total	0.7	0.69	-0.14	0.62	0.59	0.44	0.51	0.58	0.76	0.81	0.9		0.64	0.68	0.41	0.68	0.2	0.62	-0.51	-0.63	0.61	0.61	0.15	0.71	-0.15	0.69
Non Currrent Assets Other	0.67	0.8	0.12	0.72	0.81	0.34	0.51	0.61	0.55	0.39	0.37	0.64		0.39	0.7	0.73	-0.07	0.79	-0.76	-0.59	0.81	0.81	0.19	0.68	-0.22	0.74
Non Current Liabilities Total	0.78	0.63	-0.41	0.39	0.45	0.89	0.13	0.6	0.97	0.3	0.55	0.68	0.39		0.31	0.76	-0.14	0.6	-0.53	-0.8	0.6	0.6	0.0	0.76	0.07	0.74
Other Current Assets	0.74	0.81	0.36	0.91	0.84	0.49	0.8	0.77	0.47	0.07	0.09	0.41	0.7	0.31		0.77	-0.19	0.84	-0.94	-0.76	0.87	0.87	0.65	0.76	-0.64	0.81
Other Stockholder Equity	0.98	0.95	0.06	0.79	0.87	0.78	0.53	0.81	0.88	0.19	0.36	0.68	0.73	0.76	0.77		-0.16	0.94	-0.89	-0.92	0.94	0.94	0.31	0.99	-0.27	0.99
Property Plant And Equipment Gross	-0.14	0.04	-0.22	-0.17	0.1	-0.36	-0.02	-0.3	-0.15	0.48	0.39	0.2	-0.07	-0.14	-0.19	-0.16		0.01	0.2	0.31	-0.14	-0.14	-0.11	-0.11	0.07	-0.16
Total Current Assets	0.93	1.0	0.1	0.8	0.98	0.61	0.54	0.68	0.75	0.24	0.33	0.62	0.79	0.6	0.84	0.94	0.01		-0.94	-0.79	0.98	0.98	0.29	0.94	-0.3	0.95
Net Debt	-0.87	-0.92	-0.19	-0.87	-0.91	-0.65	-0.64	-0.76	-0.67	-0.11	-0.19	-0.51	-0.76	-0.53	-0.94	-0.89	0.2	-0.94		0.84	-0.97	-0.97	-0.47	-0.88	0.47	-0.92
Retained Earnings	-0.9	-0.79	-0.07	-0.8	-0.68	-0.9	-0.61	-0.92	-0.87	-0.12	-0.33	-0.63	-0.59	-0.8	-0.76	-0.92	0.31	-0.79	0.84		-0.81	-0.81	-0.46	-0.91	0.39	-0.92
Cash	0.93	0.98	0.11	0.82	0.96	0.62	0.55	0.7	0.74	0.21	0.3	0.61	0.81	0.6	0.87	0.94	-0.14	0.98	-0.97	-0.81		1.0	0.32	0.93	-0.33	0.95
Cash And Short Term Investments	0.93	0.98	0.11	0.82	0.96	0.62	0.55	0.7	0.74	0.21	0.3	0.61	0.81	0.6	0.87	0.94	-0.14	0.98	-0.97	-0.81	1.0		0.32	0.93	-0.33	0.95
Net Receivables	0.28	0.26	0.33	0.62	0.3	0.3	0.85	0.59	0.08	-0.08	-0.07	0.15	0.19	0.0	0.65	0.31	-0.11	0.29	-0.47	-0.46	0.32	0.32		0.33	-0.98	0.35
Common Stock Total Equity	1.0	0.95	0.06	0.79	0.87	0.76	0.54	0.78	0.88	0.23	0.41	0.71	0.68	0.76	0.76	0.99	-0.11	0.94	-0.88	-0.91	0.93	0.93	0.33		-0.3	0.99
Inventory	-0.25	-0.27	-0.3	-0.58	-0.33	-0.22	-0.83	-0.49	-0.02	0.04	0.07	-0.15	-0.22	0.07	-0.64	-0.27	0.07	-0.3	0.47	0.39	-0.33	-0.33	-0.98	-0.3		-0.32
Common Stock	0.99	0.96	0.09	0.83	0.89	0.77	0.57	0.81	0.87	0.21	0.38	0.69	0.74	0.74	0.81	0.99	-0.16	0.95	-0.92	-0.92	0.95	0.95	0.35	0.99	-0.32

Click cells to compare fundamentals

Prothena Plc Account Relationship Matchups

Prothena Plc balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	39.9M	39.9M	48.5M	47.4M	53.2M	35.1M
Total Assets	419.3M	333.0M	609.4M	758.0M	696.4M	414.8M
Other Current Liab	6.8M	10.7M	10.2M	16.5M	29.3M	30.7M
Total Current Liabilities	17.7M	25.8M	33.5M	50.1M	56.9M	59.7M
Total Stockholder Equity	272.9M	184.0M	466.0M	622.0M	561.4M	325.8M
Accounts Payable	1.2M	4.1M	3.7M	9.3M	25.4M	26.7M
Other Assets	13.7M	31.1M	10.4M	30.9M	35.6M	37.3M
Total Liab	146.3M	149.0M	143.3M	136.0M	135.0M	89.0M
Property Plant Equipment	3.9M	2.6M	2.0M	8.0M	9.2M	16.9M
Property Plant And Equipment Net	27.1M	20.4M	14.1M	8.0M	16.0M	22.5M
Non Current Assets Total	40.9M	33.7M	24.6M	38.9M	57.1M	36.0M
Non Currrent Assets Other	3.8M	1.7M	3.4M	12.7M	7.2M	4.7M
Liabilities And Stockholders Equity	419.3M	333.0M	609.4M	758.0M	696.4M	446.4M
Non Current Liabilities Total	128.6M	123.1M	109.9M	85.8M	78.1M	67.8M
Other Current Assets	2.7M	3.9M	10.7M	15.6M	15.3M	16.1M
Other Stockholder Equity	944.4M	966.6M	1.2B	1.5B	1.5B	822.4M
Property Plant And Equipment Gross	27.1M	20.4M	14.1M	8.0M	23.4M	22.3M
Total Current Assets	378.4M	299.3M	584.8M	719.1M	639.3M	410.5M
Net Debt	(352.8M)	(277.5M)	(566.8M)	(703.9M)	(607.0M)	(576.6M)
Retained Earnings	(671.9M)	(783.0M)	(716.1M)	(833.0M)	(980.0M)	(931.0M)
Cash	375.7M	295.4M	579.1M	710.4M	618.8M	437.9M
Cash And Short Term Investments	375.7M	295.4M	579.1M	710.4M	618.8M	437.9M
Net Receivables	68K	15K	13K	62K	5.2M	5.4M
Net Tangible Assets	272.9M	184.0M	466.0M	622.0M	715.3M	381.1M
Retained Earnings Total Equity	(598.0M)	(671.9M)	(783.0M)	(716.1M)	(644.4M)	(676.7M)
Capital Surpluse	920.6M	944.4M	966.6M	1.2B	1.4B	801.6M
Deferred Long Term Liab	254K	110.4M	110.2M	102.9M	118.4M	124.3M
Short Term Debt	5.1M	11.0M	11.9M	12.9M	2.2M	2.1M
Non Current Liabilities Other	18.4M	12.9M	6.9M	553K	497.7K	472.8K
Short Long Term Debt Total	22.9M	17.8M	12.3M	6.5M	11.8M	22.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

When determining whether Prothena plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Prothena Plc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Prothena Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Prothena Plc Stock:

How To Invest In Prothena

Details

Is Prothena Stock a good investment?

Details

What is Prothena Plc's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.

You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prothena Plc. If investors know Prothena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prothena Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.46)

Revenue Per Share

2.482

Quarterly Revenue Growth

(0.99)

Return On Assets

(0.16)

Return On Equity

(0.23)

The market value of Prothena plc is measured differently than its book value, which is the value of Prothena that is recorded on the company's balance sheet. Investors also form their own opinion of Prothena Plc's value that differs from its market value or its book value, called intrinsic value, which is Prothena Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prothena Plc's market value can be influenced by many factors that don't directly affect Prothena Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Prothena Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prothena Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prothena Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Prothena Historical Balance Sheet

Prothena Plc Inventory

(4.9 Million)

About Prothena Balance Sheet Analysis

Prothena Plc Balance Sheet Chart

Common Stock Shares Outstanding

Total Assets

Total Current Liabilities

Prothena Plc balance sheet Correlations

Prothena Plc Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Prothena Plc balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock Total Equity	+ 1.0	Common Stock Shares Outstanding
Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 0.99	Common Stock Shares Outstanding
Common Stock Total Equity	+ 0.99	Other Stockholder Equity
Common Stock	+ 0.99	Other Stockholder Equity

Inventory	- 0.98	Net Receivables
Cash And Short Term Investments	- 0.97	Net Debt
Cash	- 0.97	Net Debt
Net Debt	- 0.94	Total Current Assets
Net Debt	- 0.94	Other Current Assets
Common Stock	- 0.92	Retained Earnings